Plain-English translation of NCT05738187 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a pilot study testing cryotherapy—a minimally invasive procedure that uses extreme cold to freeze and destroy cancer cells—for head and neck cancer that has returned in areas previously treated with radiation. The study will enroll 15 patients and evaluate whether this freezing treatment is both safe and effective in controlling the cancer with fewer side effects than other options like repeat radiation.
When head and neck cancer comes back after radiation treatment, options are limited. Surgery may not be possible, repeat radiation can cause serious damage, and standard chemotherapy alone offers limited survival benefit. This medication is being tested because freezing cancer cells is a newer technique used successfully for other cancers, and early evidence suggests it may control tumors with a better safety profile than re-irradiation.
You likely qualify if…
You likely don't qualify if…
As a participant, you would undergo a cryotherapy procedure where a doctor uses freezing technology to target your recurring cancer in the previously irradiated area. This is a minimally invasive treatment, meaning it involves smaller incisions than traditional surgery. You would need to attend visits for the procedure itself, imaging tests (like MRI), and follow-up appointments to monitor how well the treatment worked and check for any side effects.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
France